NDC 68084-487-11

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
68084-487
Requested NDC
68084-487-11
Package NDCs from labels
68084-487-11
Manufacturer
National Council for Prescription Drug Programs
Effective date
2012-07-24
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
National Council for Prescription Drug Programs indexing - billing unitNational Council for Prescription Drug Programs2012-07-24Indexing - Billing Unit

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
68084-487-11EA - Each68084-487fcdbb65c-c0ba-4d07-ae7b-38bd7bd4b2ad12012-07-24
68084-487-21EA - Each68084-48788ee6149-bc15-47ee-8480-fe060240b0f712012-07-24

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Bisoprolol FumarateBISOPROLOL FUMARATEBryant Ranch Prepack6ebe6ec0-6223-425c-9f3b-8ab8dd8b3f5f2026-04-09Warnings, Adverse reactionsExact identifier
application number: ANDA075643
Bisoprolol FumarateBISOPROLOL FUMARATEAdvagen Pharma Ltd83e4b4e5-9130-44c8-abab-fcd0db5d8c492025-11-12Warnings, Adverse reactionsExact identifier
application number: ANDA075643
Bisoprolol FumarateBISOPROLOL FUMARATETruPharma LLC0ef9e45c-21ee-4e00-a9b8-280e2035b4d32025-04-17Warnings, Adverse reactionsExact identifier
application number: ANDA075643

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.